piracetam has been researched along with Porphyria Cutanea Tarda in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilo, L | 1 |
| Meo, R | 1 |
| Fulvia de Leva, M | 1 |
1 other study available for piracetam and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tarda.
Topics: Administration, Oral; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Epilepsy, Tonic-Clonic | 2006 |